Desiree Van Der Kleij

Title: **Desiree Van Der Kleij: Innovator in Antimicrobial Peptides**

Introduction

Desiree Van Der Kleij is a notable inventor based in Zoetermeer, Netherlands. With a strong focus in the field of antimicrobial peptides, she has made significant contributions through her innovative inventions. Her passion for research and development has led her to secure multiple patents, showcasing her expertise and dedication to advancing medical therapies.

Latest Patents

Desiree has been awarded a total of three patents, with her latest innovations centered around derivatives of CMAP27. The invention emphasizes the creation of antimicrobial peptides that exhibit excellent antimicrobial activity while maintaining low hemolytic activity compared to the wild-type CMAP27 peptide. These groundbreaking derivatives are intended for use in antibiotic therapy or as part of bacteriocidal compositions. Additionally, the invention explores the potential application of CMAP27 and its derivatives as adjuvants, highlighting their versatility and promise in enhancing therapeutic outcomes.

Career Highlights

Desiree is associated with Universiteit Utrecht Holding B.V., where she continues her research and innovation in antimicrobial therapies. Her work is characterized by a commitment to addressing pressing health challenges through scientific advancements. The innovative nature of her patents is a testament to her ability to transform ideas into tangible solutions that can improve patient care and treatment options.

Collaborations

In her professional journey, Desiree has collaborated with esteemed colleagues such as Floris Jacob Bikker and Albert Van Dijk. These partnerships have enabled her to combine various expertise and perspectives, further enriching the research environment and accelerating innovation in antimicrobial therapies.

Conclusion

Desiree Van Der Kleij stands out as a prominent inventor in the field of antimicrobial peptides. Her contributions, encapsulated in her recent patents, not only reflect her innovative spirit but also her commitment to enhancing medical treatments. As she continues her work at Universiteit Utrecht Holding B.V., her future inventions are anticipated to make a lasting impact on the field of medicine and beyond.